Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

Long Buu Huynh, Mercer University College of Pharmacy

Osteoporosis, or “porous bone”, is a bone disease characterized by a loss of bone mass and change in bone structure. There are no symptoms since osteoporosis is a silent condition. Risk factors that can cause osteoporosis are lifestyle choices, certain diseases, medications, and age. [1] Romosozumab is a medication used to help increase bone formation and decrease bone resorption. Alendronate is classified as an antiresorptive agent and used as first-line therapy for osteoporosis. The aim of this study is to investigate the effectiveness of romosozumab followed by alendronate compared with alendronate alone in postmenopausal women with osteoporosis and a previous fracture. [2]

Continue reading


Chlorhexidine Bathing and Health Care-Associated Infections

Diana Lee, Mercer University College of Pharmacy 2015

Recently, there has been a substantial concern for health care-associated infections with support for universal decolonization strategies, especially in high-risk patients.1  Chlorhexidine baths are a standard in many intensive care units (ICU) today to address this increasing concern with its use being recommended by some expert guidelines.2  This new study may provide some new insight into its use and effectiveness in the ICU setting.

Continue reading